Allelotyping of endometriosis with adjacent ovarian carcinoma reveals evidence of a common lineage.

PubWeight™: 1.12‹?› | Rank: Top 10%

🔗 View Article (PMID 9563487)

Published in Cancer Res on April 15, 1998

Authors

X Jiang1, S J Morland, A Hitchcock, E J Thomas, I G Campbell

Author Affiliations

1: Obstetrics and Gynecology, University of Southampton, Princess Anne Hospital, United Kingdom.

Articles citing this

Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer--shifting the paradigm. Hum Pathol (2011) 5.53

The role of the fallopian tube in the origin of ovarian cancer. Am J Obstet Gynecol (2013) 2.47

Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features. Virchows Arch (2012) 1.80

Ovarian cancer in endometriosis: molecular biology, pathology, and clinical management. Int J Clin Oncol (2009) 1.34

Loss of ARID1A expression is an early molecular event in tumor progression from ovarian endometriotic cyst to clear cell and endometrioid carcinoma. Int J Gynecol Cancer (2012) 1.26

Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles. Mod Pathol (2013) 1.04

Pathogenesis of ovarian clear cell adenofibroma, atypical proliferative (borderline) tumor, and carcinoma: clinicopathologic features of tumors with endometriosis or adenofibromatous components support two related pathways of tumor development. J Cancer (2011) 1.03

Pathogenesis and the role of ARID1A mutation in endometriosis-related ovarian neoplasms. Adv Anat Pathol (2013) 0.99

Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PLoS One (2013) 0.86

The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nat Rev Cancer (2016) 0.81

P53 codon 11, 72, and 248 gene polymorphisms in endometriosis. Int J Biol Sci (2006) 0.80

Endometriosis: a new cellular and molecular genetic approach for understanding the pathogenesis and evolutivity. Front Surg (2014) 0.79

Aberrant expression of p27(Kip1)-interacting cell-cycle regulatory proteins in ovarian clear cell carcinomas and their precursors with special consideration of two distinct multistage clear cell carcinogenetic pathways. Virchows Arch (2009) 0.78

Endometriosis-associated Malignancy. Geburtshilfe Frauenheilkd (2016) 0.77

An allelotype analysis indicating the presence of two distinct ovarian clear-cell carcinogenic pathways: endometriosis-associated pathway vs. clear-cell adenofibroma-associated pathway. Virchows Arch (2009) 0.77

Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma. Am J Cancer Res (2015) 0.77

Gene Set-Based Integrative Analysis Revealing Two Distinct Functional Regulation Patterns in Four Common Subtypes of Epithelial Ovarian Cancer. Int J Mol Sci (2016) 0.75

Clear Cell Adenocarcinoma Arising from Adenofibroma in a Patient with Endometriosis of the Ovary. J Pathol Transl Med (2015) 0.75

Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma. PLoS One (2016) 0.75

Clinicopathological heterogeneity in ovarian clear cell adenocarcinoma: a study on individual therapy practice. Med Mol Morphol (2014) 0.75

A case of ovarian mucinous adenocarcinoma in a premenarcheal girl. Int J Clin Oncol (2011) 0.75

Articles by these authors

Error, stress, and teamwork in medicine and aviation: cross sectional surveys. BMJ (2000) 13.66

The incidence and nature of surgical adverse events in Colorado and Utah in 1992. Surgery (1999) 10.85

Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation (1999) 8.17

The phosphatidylinositol 3'-kinase p85alpha gene is an oncogene in human ovarian and colon tumors. Cancer Res (2001) 4.63

Rapid and sensitive method for detection of Shiga-like toxin-producing Escherichia coli in ground beef using the polymerase chain reaction. Appl Environ Microbiol (1992) 3.14

Detection and characterization of the eae gene of Shiga-like toxin-producing Escherichia coli using polymerase chain reaction. J Clin Microbiol (1993) 3.03

A comparison of iatrogenic injury studies in Australia and the USA. II: Reviewer behaviour and quality of care. Int J Qual Health Care (2000) 2.68

Negligent care and malpractice claiming behavior in Utah and Colorado. Med Care (2000) 2.51

Understanding diagnostic errors in medicine: a lesson from aviation. Qual Saf Health Care (2006) 2.29

Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. Cancer Res (1998) 2.07

Right heart catheterization and cardiac complications in patients undergoing noncardiac surgery: an observational study. JAMA (2001) 1.99

Defining and classifying medical error: lessons for patient safety reporting systems. Qual Saf Health Care (2004) 1.87

Adenosine, inosine, and hypoxanthine/xanthine measured in tissue and plasma by a luminescence method. Clin Chem (1990) 1.69

Variation in caregiver perceptions of teamwork climate in labor and delivery units. J Perinatol (2006) 1.62

Characterization of human purified epithelial and stromal cells from endometrium and endometriosis in tissue culture. Fertil Steril (1992) 1.58

BRCA1 mutations in southern England. Br J Cancer (1998) 1.55

Building a research career in general internal medicine: a perspective from young investigators. J Gen Intern Med (1998) 1.50

Internight reliability and benchmark values for computer analyses of non-rapid eye movement (NREM) and REM EEG in normal young adult and elderly subjects. Clin Neurophysiol (2001) 1.50

Loss of heterozygosity and amplification on chromosome 11q in human ovarian cancer. Br J Cancer (1993) 1.44

Needs assessment to improve neonatal intensive care in Mexico. Paediatr Int Child Health (2015) 1.40

Expression of integrin adhesion molecules in endometrium and endometriosis. Br J Obstet Gynaecol (1994) 1.40

Nerve injury at abdominal hysterectomy. Br J Obstet Gynaecol (1995) 1.38

Suppression of gonadotrophin secretion does not reverse premature ovarian failure. Br J Obstet Gynaecol (1989) 1.37

Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry. Eur J Neurol (2006) 1.33

Effects of hypnotics on the sleep EEG of healthy young adults: new data and psychopharmacologic implications. J Psychiatr Res (2001) 1.30

Endometriosis: its association with retrograde menstruation, dysmenorrhoea and tubal pathology. Br J Obstet Gynaecol (1986) 1.23

Preschool vision screening: outcome of children referred to the hospital eye service. Br J Ophthalmol (1996) 1.21

State-dependent changes in hippocampal grey matter in depression. Mol Psychiatry (2012) 1.20

Polymorphic variation in CYP19 and the risk of breast cancer. Carcinogenesis (2001) 1.19

The effect of aerobic exercise training on the lipid-lipoprotein profile of children and adolescents. Sports Med (2000) 1.19

Formal selection of measures for a composite index of NICU quality of care: Baby-MONITOR. J Perinatol (2011) 1.19

Allele loss and mutation screen at the Peutz-Jeghers (LKB1) locus (19p13.3) in sporadic ovarian tumours. Br J Cancer (1999) 1.16

Endometriosis. BMJ (1993) 1.16

Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist. Br Med J (Clin Res Ed) (1986) 1.15

High internight reliability of computer-measured NREM delta, sigma, and beta: biological implications. Biol Psychiatry (2000) 1.11

Molecular genetic defects in endometriosis. Gynecol Obstet Invest (2000) 1.11

Microsatellite analysis of endometriosis reveals loss of heterozygosity at candidate ovarian tumor suppressor gene loci. Cancer Res (1996) 1.10

Interaction of primary human endometrial cells with Neisseria gonorrhoeae expressing green fluorescent protein. Mol Microbiol (2000) 1.09

Complement activation in asymptomatic patients with sickle cell anaemia. Clin Exp Immunol (1979) 1.07

Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Cancer Res (1996) 1.05

Primary cervical lymphoma: the role of cervical cytology. Cytopathology (1996) 1.02

Semen characteristics of 49 fertile males. Andrologia (1988) 1.01

Ketamine administration during waking increases delta EEG intensity in rat sleep. Neuropsychopharmacology (1993) 1.00

Diagnosis of isolated small bowel injury following blunt abdominal trauma. Ann Emerg Med (1983) 0.99

Massive hemoperitoneum from transhepatic perforation of the gallbladder: a rare complication of cholelithiasis. Surgery (1989) 0.99

Electrohydraulic lithotripsy of gall stones--in vitro and animal studies. Gut (1987) 0.98

Microsomal epoxide hydrolase polymorphism and susceptibility to ovarian cancer. Cancer Lett (2002) 0.98

Activation of the alternative pathway of human complement by haemoglobin. Clin Exp Immunol (1979) 0.96

ST7-mediated suppression of tumorigenicity of prostate cancer cells is characterized by remodeling of the extracellular matrix. Oncogene (2006) 0.95

MDM2 overexpression is rare in ovarian carcinoma irrespective of TP53 mutation status. Br J Cancer (1995) 0.95

Tumour marker immunoreactivity in adenocarcinoma. J Clin Pathol (1988) 0.95

p53 polymorphism in ovarian and breast cancer. Lancet (1996) 0.95

Prognostic value of cardiac troponin T after noncardiac surgery: 6-month follow-up data. J Am Coll Cardiol (1997) 0.94

Loss of heterozygosity on chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis. Oncogene (1998) 0.94

GSTM1 null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis (2001) 0.94

Properties of the reaction of cis-dichlorodiammineplatinum(II) with metallothionein. J Biol Chem (1992) 0.94

Exercise training induced alterations in prepubertal children's lipid-lipoprotein profile. Med Sci Sports Exerc (1998) 0.93

Localization of an ovarian cancer tumor suppressor gene to a 0.5-cM region between D22S284 and CYP2D, on chromosome 22q. Cancer Res (1996) 0.93

Invasive cervical cancer in Southampton and South West Hampshire: effect of introducing a comprehensive screening programme. J Med Screen (1996) 0.93

Endometriosis: candidate genes. Hum Reprod Update (2001) 0.93

Impact of gestrinone on the course of asymptomatic endometriosis. Br Med J (Clin Res Ed) (1987) 0.93

Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Br J Cancer (1996) 0.92

No association of a 306-bp insertion polymorphism in the progesterone receptor gene with ovarian and breast cancer. Br J Cancer (1997) 0.92

Changing Australian prescribing patterns for antiepileptic drugs in pregnancy and their possible consequences. J Clin Neurosci (2007) 0.91

Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest (2000) 0.91

Mutation of the ST7 tumor suppressor gene on 7q31.1 is rare in breast, ovarian and colorectal cancers. Nat Genet (2001) 0.89

Loss of heterozygosity on chromosome 22 in ovarian carcinoma is distal to and is not accompanied by mutations in NF2 at 22q12. Br J Cancer (1994) 0.89

Synchronous ovarian and cervical squamous intraepithelial neoplasia: an analysis of HPV status. Gynecol Oncol (1998) 0.89

Short report: identification of a specific pattern of vascular endothelial growth factor mRNA expression in human placenta and cultured placental fibroblasts. Placenta (1994) 0.88

Sensitivity and specificity of an enzyme-linked immunosorbent assay for the detection of bovine viral diarrhea virus antibody in cattle. Can J Vet Res (1991) 0.88

The impact of a tele-ICU on provider attitudes about teamwork and safety climate. Qual Saf Health Care (2010) 0.87

Evolution and spread of IncFIV plasmids conferring resistance to trimethoprim. Antimicrob Agents Chemother (1986) 0.87

Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. J Natl Cancer Inst (2001) 0.86

Anatomy of a patient safety event: a pediatric patient safety taxonomy. Qual Saf Health Care (2005) 0.86

Pituitary and ovarian hormone levels in unexplained menorrhagia. Obstet Gynecol (1994) 0.86

Genomic organization of the human folate receptor genes on chromosome 11q13. Genomics (1992) 0.86

Gonadotrophin regulation of production of tissue inhibitor of metalloproteinases-1 by luteinized human granulosa cells: a potential mechanism for luteal rescue. Mol Hum Reprod (1997) 0.86

Mutation analysis of RASK and the 'FLR exon' of NF1 in sporadic ovarian carcinoma. Eur J Cancer (1994) 0.86

TP53 intron 6 polymorphism and the risk of ovarian and breast cancer. Br J Cancer (1998) 0.85

Immunohistochemical localization of acidic and basic fibroblast growth factors in normal human endometrium and endometriosis and the detection of their mRNA by polymerase chain reaction. Hum Reprod (1993) 0.85

Haematemesis and ectopic pregnancy. Br Med J (Clin Res Ed) (1984) 0.85

Ion transport by human endometrial epithelia in vitro. Hum Reprod (1993) 0.85

Endometrial progesterone receptor expression during the human menstrual cycle. J Reprod Fertil (1996) 0.85

Retinoic acid receptors and retinoid binding proteins in endometrial adenocarcinoma: differential expression of cellular retinoid binding proteins in endometrioid tumours. Int J Cancer (1995) 0.84

The influence of recovery posture on post-exercise hypotension in normotensive men. Med Sci Sports Exerc (2001) 0.84

BRCA1 polymorphisms. Br J Cancer (1997) 0.84

Ovarian steroid receptor expression in endometriosis and in two potential parent epithelia: endometrium and peritoneal mesothelium. Hum Reprod (1992) 0.84

Stimulation of NREM delta EEG by ketamine administration during waking: demonstration of dose dependence. Neuropsychopharmacology (1995) 0.84

Epidermal growth factor in human endometrium: proliferative effects in culture and immunocytochemical localization in normal and endometriotic tissues. Hum Reprod (1991) 0.84

Troponin T as a marker for myocardial ischemia in patients undergoing major noncardiac surgery. Am J Cardiol (1996) 0.84